Synergistic Combinations for Advanced Gynecological Treatment

Integrating ozonized olive oil with AI, IoT, blockchain, and novel materials to create a powerful system for treating and preventing vulvovaginitis, enhancing treatment efficacy, patient compliance, and overall women's health.

The original patent addressed the need for a natural composition for treating vulvovaginitis. However, the invention had limitations in terms of tracking treatment efficacy, patient compliance, and optimal storage and handling. The new inventive concept addresses these limitations by incorporating synergistic combinations of distinct technologies.

The new inventive concept combines the ozonized olive oil with advanced technologies to create a comprehensive system. The blockchain-based tracking module ensures secure and transparent monitoring of treatment efficacy and patient compliance. The AI-powered diagnostic tool identifies high-risk patients, enabling targeted prevention and early intervention. The IoT-enabled temperature control system optimizes storage and handling conditions. The novel biodegradable packaging material derived from plant-based polymers reduces environmental impact. The machine learning algorithm predicts treatment outcomes based on patient data and treatment parameters, enabling data-driven decision-making.

The new claims introduce novel combinations of ozonized olive oil with AI, IoT, blockchain, and novel materials, providing a synergistic system that enhances treatment efficacy, patient compliance, and overall women's health. These combinations are non-obvious and represent a significant departure from the original patent.

Alternative embodiments may include integrating the ozonized olive oil with other AI-powered diagnostic tools, such as machine learning-based image analysis or natural language processing. Variations may include using different types of novel materials, such as graphene or nanomaterials, to enhance the system's performance and sustainability.

The inventive concept has significant commercial potential in the gynecological treatment market, particularly in the areas of vulvovaginitis prevention and treatment. The system's ability to enhance treatment efficacy, patient compliance, and overall women's health makes it an attractive solution for healthcare providers, patients, and pharmaceutical companies. The market potential is substantial, with an estimated global value of USD 10 billion by 2025.